butabarbital will lessen the extent or outcome of fedratinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Outcome of coadministering a strong CYP3A4 inducer with fedratinib has not been researched.Butabarbital, most often often called Butisol commercially, is really an authorised Routine III drug